Association between neurexin 1 (NRXN1) polymorphisms and the smoking behavior of elderly Japanese
Association between neurexin 1 (NRXN1) polymorphisms and the smoking behavior of elderly Japanese
复制标题
DOI:
10.1097/ypg.0b013e32833a21f9
复制
发表时间:
2010-06-01
影响因子:
0.9
通讯作者:
Sugimura, Haruhiko
中科院分区:
文献类型:
--
作者:
Sato, Naomi;Kageyama, Shinji;Sugimura, Haruhiko
Neurexin 1 (NRXN1, MIM 600565) is a molecule that is expressed in neurons and is a receptor for α-latrotoxin (Rowen et al., 2002). Bierut et al.(2007) pinpointed the NRXN1 gene locus as being responsible for nicotine dependence in a case–control analysis in which the cases were American and Australian smokers whose Fagerström Test for Nicotine Dependence (FTND) score was 4 or more. The other group also documented a significant contribution of the polymorphism at the NRXN1 locus to nicotine dependence in the European–American and African–American populations (Nussbaum et al., 2008). They evaluated 21 NRXN1 polymorphisms in European–American and African–American smokers for associations with FTND scores, number of cigarettes smoked per day (CPD), and the heaviness of smoking index, which is a combination of CPD and time before the first cigarette of the day. The results showed that two of 21 single nucleotide polymorphisms, rs2193225 and rs6721498, were associated with heaviness of smoking index and FTND scores in some American populations of European and African origin. In this letter, we report the evaluation of these polymorphisms in an elderly Japanese population (60–94 years old) according to smoking history. The rs6721498 and rs2193225 were genotyped in 2516 Japanese with various smoking habits [1348 ever-smokers (current smokers and ex-smokers; 83.6%) among the 1612 male participants and 82 (9.1%) among the 904 female participants, and current smokers were 21.6 and 3.4% of the male and female participants, respectively]. FTND and the Tobacco Dependence Screener (TDS), which was developed so that the characteristics detected would be more closely correlated with those defined by the International Statistical Classification of Diseases and Related Health Problems, 10th version, Diagnostic and